'Three-parent babies' public consultation launched

September 17, 2012
Vials are prepared for DNA testing in a lab. The British public are being consulted on the ethics of a fertility treatment that uses DNA from a third parent to help eliminate genetic diseases, the government announced on Monday.

The British public are being consulted on the ethics of a fertility treatment that uses DNA from a third parent to help eliminate genetic diseases, the government announced on Monday.

The results of the consultation will help inform a decision by Jeremy Hunt on whether to legalise the treatment as early next year—potentially making Britain the first country in the world to hold human trials into the treatment, the Daily Telegraph reported.

The IVF-based technique is designed to avoid serious inherited on the maternal side, such as , by replacing some of the with healthy DNA from the so-called "third parent".

One in 200 children are born each year with a form of disease in their mitochondrial DNA, the structures within cells that convert energy from food into a form that the body can use.

Many of those children have mild to no symptoms, and may never even have the disease diagnosed, the Human Fertilisation and Embryology Authority, which is overseeing the consultation, said in a press statement.

Others can have severe, even life-shortening symptoms such as muscular weakness or heart disease. The Telegraph reported that up to one in 6,500 people born in Britain each year suffer severe symptoms.

Scientists are developing a technique to remove some of the mitochondrial DNA of the mother and replace it with DNA from the "third parent" to create a healthy embryo.

The technique is currently lawful in a laboratory but the embryos cannot be used in treatment, the HFEA said, calling the treatment "uncharted territory".

"Any child born following mitochondria replacement would share DNA with three people, albeit a tiny amount with the donor," the organisation said in a statement. "These changes would affect the germ line, meaning the donor's mitochondrial DNA would be passed on to ."

"We will use our considerable experience of explaining complicated areas of science and ethics to the public to generate a rich debate that is open to all," chairman Lisa Jardine said in a press release.

She stated: "We find ourselves in uncharted territory, balancing the desire to help families have healthy children with the possible impact on the children themselves and wider society."

Jardine called the decision one of "enormous public interest".

It furthers the debate on "designer babies" and the morality of engineering first fuelled by the original forays into IVF treatment.

There are also fears over how the "third parent" would affect the child's sense of identity, and what rights both the child and the third parent would have.

The consultation will run until December 7, with the public encouraged to discuss whether the clinical benefits outweigh any moral, ethical or other health concerns via the HFEA website at www.hfea.gov.uk/ .

Explore further: UK health regulators apply brakes to 'three-parent' IVF procedure

Related Stories

UK health regulators apply brakes to 'three-parent' IVF procedure

April 20, 2011
(PhysOrg.com) -- In what is rapidly turning into a political debate in the United Kingdom, members of the Human Fertilization and Embryology Authority (HFEA) have, after careful review, declined to allow legislation to be ...

Mitochondrial technique is ethical

June 12, 2012
(Medical Xpress) -- An influential independent body has found that a pioneering mitochondrial transfer technique is ethical. Developed by a team at Newcastle University, the technique aims to prevent the transmission of maternally ...

UK group: New embryo methods should be allowed

June 11, 2012
(AP) — An influential British bioethics group says that couples who face the risk of having a baby with certain genetic diseases should be allowed to use eggs from two women to produce the embryo.

Recommended for you

Women exposed to smoke while in womb more likely to miscarry

July 13, 2017
Women exposed to cigarette smoke while in their mothers' wombs are more likely to experience miscarriage as adults, according to new research from the University of Aberdeen.

Lack of a hormone in pregnant mice linked to preeclampsia

June 30, 2017
(Medical Xpress)—A team of researchers from Singapore, the Netherlands and Turkey has isolated a hormone in pregnant mice that appears to be associated with preeclampsia—a pregnancy-related condition characterized by ...

Aspirin reduces risk of pre-eclampsia in pregnant women

June 28, 2017
Taking a low-dose aspirin before bed can reduce the risk of pre-eclampsia, which can cause premature birth and, in extreme cases, maternal and foetal death.

The biology of uterine fluid: How it informs the fetus of mom's world

June 22, 2017
A developing fetus bathes in a mixture of cellular secretions and proteins unique to its mother's uterus. Before fertilization, the pH of uterine fluid helps create a conducive environment for sperm migration, and afterward, ...

New clues in puzzle over pre-eclampsia and cholesterol regulation

June 21, 2017
Scientists studying a mystery link between the dangerous pregnancy complication pre-eclampsia and an increased risk of heart disease in later life for both mother and child have uncovered important new clues.

Are maternal hormones different when carrying a boy or a girl?

June 15, 2017
With advances in prenatal testing it's now possible to find out whether a pregnancy will result in a male or female baby as early as eight weeks' gestation.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Tausch
not rated yet Sep 17, 2012
The forensics of DNA must adapt to chimeric research.
Chimeric research vows to change the evolution of genetics.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.